Molecular Staging Inc.

Molecular Staging is a biotechnology company spun out of Yale University to commercialize research and diagnostic applications of a novel molecular amplification technology - rolling circle amplification. Molecular Staging raised more than $80M in venture capital and developed technolgies that transformed the way genomes are sequenced (TempliPhi), whole genome molecular genetic studies (GenomiPhi and others), and protein microarray technology development. Molecular Staging was acquired by Qiagen in 2004. GE Healthcare retains commercial rights to TempliPhi and GenomiPhi.